首页> 外文OA文献 >Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology
【2h】

Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology

机译:与年龄匹配的无恶性组织学的前列腺样品相比,前列腺癌和正常出现的邻近腺体中的体细胞线粒体DNA突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Studies of somatic mitochondrial DNA mutations have become an important aspect of cancer research because these mutations might have functional significance and/or serve as a biosensor for tumor detection. Here we report somatic mitochondrial DNA mutations from three specific tissue types (tumor, adjacent benign, and distant benign) recovered from 24 prostatectomy samples. Needle biopsy tissue from 12 individuals referred for prostate biopsy, yet histologically benign (symptomatic benign), were used as among individual control samples. We also sampled blood (germplasm tissue) from each patient to serve as within individual controls relative to the somatic tissues sampled (malignant, adjacent, and distant benign). Complete mitochondrial genome sequencing was attempted on each sample. In contrast to both control groups [within patient (blood) and among patient (symptomatic benign)], all of the tissue types recovered from the malignant group harbored significantly different mitochondrial DNA (mtDNA) mutations. We conclude that mitochondrial genome mutations are an early indicator of malignant transformation in prostate tissue. These muta-tions occur well before changes in tissue histo-pathology, indicative of prostate cancer, are evident to the pathologist.
机译:体细胞线粒体DNA突变的研究已成为癌症研究的重要方面,因为这些突变可能具有功能意义和/或充当肿瘤检测的生物传感器。在这里,我们报告了从24种前列腺切除术样本中回收的三种特定组织类型(肿瘤,邻近良性和远处良性)的体细胞线粒体DNA突变。来自12个进行前列腺穿刺活检的个体的针头活检组织,但在组织学上是良性的(有症状的良性),被用作单个对照样本。我们还从每个患者中抽取血液(种质组织)作为相对于所抽取的体细胞组织(恶性,邻近和远处的良性)的单独对照。尝试对每个样品进行完整的线粒体基因组测序。与两个对照组[在患者(血液内)和患者之间(有症状的良性)]相反,从恶性组中回收的所有组织类型均具有明显不同的线粒体DNA(mtDNA)突变。我们得出的结论是线粒体基因组突变是前列腺组织恶性转化的早期指标。这些突变发生在病理学家发现组织病理学改变之前,即表明前列腺癌的病理改变很早。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号